Advent International has outbid KKR in a private equity bidding war for Spectris after the UK industrial group accepted its ...

Advent International said it increased its takeover bid for precision-measurement company Spectris to 4.2 billion pounds ($5.55 billion).

Precision instrument maker Spectris has agreed to be bought by Advent International after it trumped an offer from US ...

(Reuters) -British scientific instruments maker Spectris has agreed to private equity firm Advent's sweetened takeover offer ...

Advent’s increased offer represents a 2.5 percent increase to the KKR offer. This means the shareholders will receive an additional £1.00 per share, amounting to a total increase of £101.5 million ...

The firm is acting for the Just Group in its £2.4 billion sale, a month after it helped conclude the sale of Spectris to a ...

British scientific instruments maker Spectris has agreed to private equity firm Advent's sweetened takeover bid valued at 4.8 billion pounds ($6.38 billion), including debt, the companies said on ...

Cognito Therapeutics today announced the presentation of new findings from a study of its non-invasive Spectris neuromodulation system.

Advent's proposal valued Spectris at 37.63 pounds per share, including dividend, representing close to an 85% premium to Spectris's last closing price. Spectris, in a statement confirming a Bloomberg ...

Cognito Therapeutics Presents Clinical Trial Data Highlighting Neuroprotective Potential of Spectris™ in Alzheimer’s Disease ...

Spectris' Earnings Growth And 10% ROE To begin with, Spectris seems to have a respectable ROE. Even when compared to the industry average of 10% the company's ROE looks quite decent.

- Spectris™ significantly decreased the Alzheimer’s Disease Dependence Score by 56.4% over 18 months, indicating preserved function and reduced caregiver burden - Strong safety profile with no ...